NCT01823822

Influence of Protein Supplements on Serum Insulin-like Growth Factor-I Levels in Women With Anorexia Nervosa

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 62 (actual)
• Sponsor: University Hospital, Geneva · Academic / Other
• Sex: Female
• Age: 18 Years – 40 Years
• Healthy volunteers: Not accepted

Summary

This multicentre, randomised, double-blind, 2-parallel group, controlled trial aims to investigate whether oral milk protein supplements led to increase in serum Insulin-like Growth Factor-I levels (IGF-I) as compared with a control group fed with an iso-caloric supplement, in women with anorexia nervosa. Subjects receive either 150g/day of tested product or control product for 4-week, followed by a 4-week follow-up.

Detailed description

Study centres: 4 active centres in France and 2 active centres in Switzerland

Conditions

• Anorexia Nervosa

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Oral protein supplement (Tested product)	Test product: oral protein supplement, sweetened flavoured dairy product, type fresh cheese rich in milk protein (15 g/150 grams). Dosage is 2 pots daily, at least 5 days/week for 4 consecutive weeks.
DIETARY_SUPPLEMENT	Iso-caloric supplement (Control product)	Control product: sweetened flavoured fresh cheese, with low milk protein content (3 g/150 grams). Dosage is 2 pots daily, at least 5 days/week for 4 consecutive weeks.

Timeline

• Start date: 2008-06-01
• Primary completion: 2009-03-01
• Completion: 2009-04-01
• First posted: 2013-04-04
• Last updated: 2013-04-04

Locations

1 site across 1 country: Switzerland